CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ARVN — Arvinas, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,505,465
-$1,061,379 QoQ
Shares Held
542,174
+3.2% QoQ
Ownership
0.829%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ARVN ranks #148 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,505,465 | 542,174 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,566,844 | 525,174 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,493,065 | 547,476 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,195,265 | 609,773 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,896,516 | 529,418 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,434,457 | 489,239 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $10,277,267 | 536,112 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $13,070,377 | 530,669 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,494,669 | 544,503 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $21,798,110 | 528,055 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $19,323,549 | 469,474 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,445,003 | 429,990 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,023,559 | 363,560 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,804,082 | 358,861 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,336,194 | 360,602 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,701,722 | 352,927 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,525,200 | 321,340 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,144,997 | 329,049 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $26,374,004 | 321,086 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $24,799,458 | 301,770 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,263,937 | 250,181 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,262,622 | 230,902 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $17,974,075 | 211,634 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,030,227 | 170,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,450,087 | 132,680 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $4,426,068 | 109,828 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||